Dr. Capalbo received his Bachelor of Science degree in Biotechnology from University of Rome ‘La Sapienza’ and his Ph.D. magna cum laude in Human Genetics at the Catholic University of Sacred Heart of Rome in 2011. From 2008 to 2012 Dr. Capalbo has been working as a clinical embryologist, pioneering embryo biopsy approaches and applications. Since then, his research has focused on preimplantation genetic testing and on the development of novel molecular biology techniques to improve pregnancy and take-home baby rates in ART. His basic research has been focused on the mechanisms of aneuploidies in oocytes and preimplantation human embryos. Since September 2022, Dr. Capalbo has served as Chief Scientific Officer at Juno Genetics, and since October 2023, he has also held a professorship at the Unit of Medical Genetics at the ‘G. d’Annunzio’ University of Chieti-Pescara. He is currently past-coordinator of the ESHRE SIG in Reproductive Genetics and a member of the genomics-working group of the Italian Society of human genetics. He has published more than 150 peer-reviewed papers and book chapters and is currently a reviewer and associated editor for many journals in the field of reproductive biology and genetics, including AE for Human Reproduction and section editor of RBMO.
